Literature DB >> 3106034

Serum bactericidal activity of ciprofloxacin and ofloxacin in volunteers.

K Machka, D Milatovic.   

Abstract

The serum bactericidal activity of two newer quinolones, ciprofloxacin and ofloxacin, against 206 clinical bacterial isolates was determined in six male volunteers after oral administration of either 500 mg of ciprofloxacin or 200 mg of ofloxacin respectively. The highest bactericidal titers were achieved against Enterobacteriaceae 1 h after ciprofloxacin administration, ranging from 1:121 for indole-positive Proteus species to 1:30 for Serratia spp. Ofloxacin generated lower titers, ranging from 1:14 for indole-positive Proteus spp. to 1:2.5 for Enterobacter spp. Only low serum bactericidal titers were found for Pseudomonas aeruginosa, Acinetobacter spp. and gram-positive cocci. It is concluded that the activity of orally administered ciprofloxacin is superior to that of orally administered ofloxacin in the serum bactericidal test.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106034     DOI: 10.1007/bf02097195

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  14 in total

1.  Comparison of the serum bactericidal activity of ceftriaxone/piperacillin and ceftriaxone/netilmicin.

Authors:  K Machka; M Röbl; I Braveny
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

2.  Evaluation of novel antipseudomonal drugs using the serum bactericidal activity test.

Authors:  I Braveny; K Machka; D Milatovic
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

3.  Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections.

Authors:  J Klastersky; D Daneau; G Swings; D Weerts
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

4.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

5.  Significance of serum bactericidal activity in gram-negative bacillary bacteremia in patients with and without granulocytopenia.

Authors:  J P Sculier; J Klastersky
Journal:  Am J Med       Date:  1984-03       Impact factor: 4.965

6.  Value of serum tests in combined drug therapy of endocarditis.

Authors:  T A Drake; C J Hackbarth; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

7.  Evaluation of the Micur microdilution systems for antibiotic susceptibility testing of gram-negative and gram-positive bacteria.

Authors:  F Kayser; K Machka; L Wieczorek; D Banauch; W Bablok; I Braveny
Journal:  Eur J Clin Microbiol       Date:  1982-12       Impact factor: 3.267

8.  Bactericidal activity of ciprofloxacin in serum and urine against Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus faecalis.

Authors:  H Lagast; M Husson; J Klastersky
Journal:  J Antimicrob Chemother       Date:  1985-09       Impact factor: 5.790

9.  Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa.

Authors:  B E Scully; H C Neu; M F Parry; W Mandell
Journal:  Lancet       Date:  1986-04-12       Impact factor: 79.321

10.  Evaluation of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections.

Authors:  H Giamarellou; N Galanakis; C Dendrinos; J Stefanou; E Daphnis; G K Daikos
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

View more
  3 in total

1.  Pharmacokinetics and serum bactericidal titers of ciprofloxacin and ofloxacin following multiple oral doses in healthy volunteers.

Authors:  D Israel; J G Gillum; M Turik; K Harvey; J Ford; H Dalton; M Towle; R Echols; A H Heller; R Polk
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

Review 2.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

3.  [Bactericidal activity of enoxacin and ciprofloxacin in body fluids].

Authors:  R Roos; A Jäger; H Kraeft; D Adam
Journal:  Infection       Date:  1989       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.